Laos vs Malaysia: Treatment coverage for lymphatic filariasis
Laos
86.8%
in 2017
Malaysia
84.2%
in 2024
Laos rank
4th
Malaysia rank
7th
Treatment coverage for lymphatic filariasis over time
- Laos
- Malaysia
How they compare
Laos currently reports 86.8% against 84.2% in Malaysia, a difference of 2.6%.
The two have swapped places 6 times across 9 shared years of data; in 2008 it was Malaysia ahead.
Laos ranks 4th and Malaysia ranks 7th of 66 countries.
Across the 2 decades both report, Laos averaged higher in 1 and Malaysia in 1.
Head to head by decade
| Decade | Laos | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 61.0% | 85.9% | 24.9% | Malaysia |
| 2010s | 75.7% | 59.5% | 16.3% | Laos |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for lymphatic filariasis, Laos or Malaysia?
- Laos, at 86.8% against 84.2% in Malaysia as of 2017.
- What is the difference in treatment coverage for lymphatic filariasis between Laos and Malaysia?
- 2.6%, with Laos ahead.
- How many years of comparable data are there for Laos and Malaysia?
- 9 years are reported by both, from 2008 to 2017.
- How do Laos and Malaysia rank globally for treatment coverage for lymphatic filariasis?
- Laos ranks 4th and Malaysia ranks 7th of 66 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Treatment coverage for lymphatic filariasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.